Scalper1 News
Biotech and pharma stocks rallied Tuesday as several leading players reported good news amid a buoyant market day. IBD 50 specialty drugmaker Salix Pharmaceuticals (SLXP) shot up to a new high of 143.98 before closing up 13.5% at 140.02. Salix said Tuesday that sufferers from irritable bowel syndrome with diarrhea showed statistically significant improvement in symptoms when they took its drug Xifaxan in a phase-three clinical trial. Scalper1 News
Scalper1 News